Publications by authors named "Dan Bloomfield"

Claim this Profile
S
Safety of Factor XI Inhibition With Abelacimab in Atrial Fibrillation by Kidney Function: A Prespecified Analysis of the AZALEA-TIMI 71 Randomized Clinical Trial.
Siddharth M Patel, Robert P Giugliano, David A Morrow, Erica L Goodrich, Sabina A Murphy, Dan Bloomfield

JAMA Cardiol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Protective effects of factor XI inhibition by abelacimab in a baboon model of live Staphylococcus aureus sepsis.
Robert Silasi, Ravi S Keshari, Tomohiro Abe, Stephanie D Byrum, Girija Regmi, Dan Bloomfield

J Thromb Haemost· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Abelacimab Versus Rivaroxaban in Patients With Atrial Fibrillation on Antiplatelet Therapy: A Prespecified Analysis of the AZALEA-TIMI 71 Trial.
Samer Al Said, Siddharth M Patel, Robert P Giugliano, David A Morrow, Erica L Goodrich, Dan Bloomfield

Circulation· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Low concentrations of recombinant activated factor VII normalize coagulation patterns by reversing the changes in viscoelastic testing parameters induced by abelacimab .
Yasser Khder, Serge Côté, Klaus Peter Hoffmann, Debra Freedholm, Dan Bloomfield

Res Pract Thromb Haemost· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparing the Real-World and Clinical Trial Bleeding Rates Associated with Oral Anticoagulation Treatment for Atrial Fibrillation.
Ying Gue, Dan Bloomfield, Debra Freedholm, Gregory Y H Lip

J Clin Med· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment of Cancer-Associated Thrombosis: Recent Advances, Unmet Needs, and Future Direction.
Tzu-Fei Wang, Alok A Khorana, Giancarlo Agnelli, Dan Bloomfield, Marc P Bonaca

Oncologist· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics and pharmacodynamics of Abelacimab (MAA868), a novel dual inhibitor of Factor XI and Factor XIa.
B Alexander Yi, Debra Freedholm, Nancy Widener, Xiaohui Wang, Emilie Simard, Dan Bloomfield

J Thromb Haemost· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Regular Doses of Nature: The Efficacy of Green Exercise Interventions for Mental Wellbeing.
Mike Rogerson, Carly Wood, Jules Pretty, Patrick Schoenmakers, Dan Bloomfield

Int J Environ Res Public Health· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
What makes nature-based interventions for mental health successful?
Dan Bloomfield

BJPsych Int· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
What approaches to social prescribing work, for whom, and in what circumstances? A protocol for a realist review.
Kerryn Husk, Kelly Blockley, Rebecca Lovell, Alison Bethel, Dan Bloomfield

Syst Rev· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis